Pancreatic Neuroendocrine Tumor (NETs) Diagnostic Testing
Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969
is still the hallmark of Inter Science Institute.
Read more about these conclusions about ISI's Pancreastatin assay providing valuable information for patients at high risk of recurrence and accurately detecting progression.
Luncheon With The Experts
On November 19th, Inter Science Institute's C.O.O., Mia S. Tepper, MBA was the featured speaker on the Carcinoid Cancer Foundation "Luncheon with the Experts".
Click the link below to view the video: https://www.facebook.com/Carcinoid/videos/1496649470530262/
The Carcinoid Cancer Foundation began as the Carcinoid Tumor and Serotonin Research Foundation in 1968 when the NIH fund for rare cancers was terminated. The name was changed to the Carcinoid Cancer Foundation in 1995. It is a nonprofit organization chartered by the State of New York for the purpose of encouraging and supporting education and research on carcinoid and related neuroendocrine cancers. For more information go to: www.carcinoid.org.
5-HIAA assay is now available on plasma (Z-tubeTM) from ISI
New test available for patients: the 5-HIAA assay is now available on plasma (Z-tubeTM) from ISI. Click here to see the requirements.
Just added: two new peer-reviewed published papers on Pancreastatin
ISI's Latest Journal Publications are Available
To learn more about how these biomarkers are used, read the paper(s) below:
Neurokinin A (NKA)
Pancreastatin
It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors
Pancreastatin Predicts Survival in Neuroendocrine Tumors
Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior
A Prospective Evaluation of the Effect of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans
Octreotide (Sandostatin®)
A Prospective Trial on the Effect of Body Mass Index and Sex on Plasma Octreotide Levels in Patients Undergoing Long-Term Octreotide LAR Therapy
Effect of Octreotide LAR Dose and Weight on Octreotide Blood Levels in Patients With Neuroendocrine Tumors
Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients
Chromogranin A
C.U.R.E.® Catalogue
The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of:
G.I. & Pancreatic Tests
Hypertension, Corticosteroid, & Mineralocorticoid Tests
Hypothalamic-pituitary Axis & Releasing Factor Tests
Multi-disciiplinary Tests
Pediatric & Enzyme Deficiency Tests
Reproductive Endocrinology & Gonadal Steroid Tests
Thyroid Tests
Please contact ISI for the most up to date testing availability.
Search Individual Assays
To Search Assays by Numbers
To Search by name:
For the Most Recent Edition of the C.U.R.E.® (Current Unique and Rare Endocrine) Catalogue please contact the Institute at: requests@InterScienceInstitute.com
ISI is the leader in neuroendocrine tumors (NET's) Biomarker Testing
Updated with ICD-10 codes
Celebrating our 50th year of continued cutting edge esoteric services to the medical, research and academic communities, Inter Science Institute specializes in research and development emphasis in the area of Neuroendocrine Tumors (NET's). The current 5th edition handbook, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, is available for download on this website or by contacting ISI at requests@interscienceinstitute.com.
Click here for the previous edition.
e-mail: requests@InterScienceInstitute.com
Inter Science Institute - 944 West Hyde Park Blvd, Inglewood, CA 90302
Contact Us: Phone 800-255-2873 | 310-677-3322 | Fax: 310-677-2846